levamisole - CISMeF

Preferred Label : levamisole;

MeSH definition : An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6);

MeSH synonym : l-tetramisole; levotetramisole;

CISMeF synonym : 16595-80-5 (Levamisole hydrochloride);

MeSH hyponym : Levamisole Hydrochloride; dekaris; solaskil; Hydrochloride, Levamisole; Decaris;

MeSH CAS label : Imidazo(2,1-b)thiazole, 2,3,5,6-tetrahydro-6-phenyl-, (S)-;

MeSH Related Number : levamisole hydrochloride; 14769-73-4 (Levamisole); 16595-80-5 (hydrochloride); DL9055K809;

Registry Number MeSH : 14769-73-4;

Related CAS MeSH : DL9055K809 (Levamisole hydrochloride);

Wikipedia link : https://en.wikipedia.org/wiki/Levamisole;

Codes EINECS : 238-836-5;

Is substance : O;

UNII : 2880D3468G;

InChIKey : HLFSDGLLUJUHTE-SNVBAGLBSA-N;

Détails

Origin ID

D007978;

UMLS CUI

C0023556;

ATC code(s)
- levamisole [ATC Code]
ATC code(s)
- levamisole [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Levamisole adverse reaction (disorder) [SNOMED CT concept]
- levamisole [Substance BNPC]
Currated CISMeF NLP mapping
- Levamisole [ICD-11 Extension code]
- Levamisole [NCIt concept]
- Levamisole [LOINC component]
- Levamisole (substance) [SNOMED CT concept]
- Product containing levamisole (medicinal product) [SNOMED CT concept]
- Tetramisole [NCIt concept]
- levamisole [SNOMED Notion]
- tetramisole [Substance BNPC]
Fils d'après SNOMED CT
- adjuvants, immunologic [MeSH Descriptor]
Indexing information
- 4-bromotetramisole [MeSH Supplementary Concept]
Pharmacological action(s)
- adjuvants, immunologic [MeSH Descriptor]
- antinematodal agents [MeSH Descriptor]
- antirheumatic agents [MeSH Descriptor]
Record concept(s)
- Levamisole Hydrochloride [MeSH concept]
- dekaris [MeSH concept]
- levamisole [MeSH concept]
- solaskil [MeSH concept]
Related MeSH Supplementary Concept(s)
- 3-aminolevamisole [MeSH Supplementary Concept]
- 4-hydroxylevamisole [MeSH Supplementary Concept]
- algalev [MeSH Supplementary Concept]
- helmoral B [MeSH Supplementary Concept]
- kamizol [MeSH Supplementary Concept]
- meitonii [MeSH Supplementary Concept]
- vermisantel [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Levamisole [LOINC component]
- Levamisole [ICD-11 Extension code]
- Levamisole [NCIt concept]
- Levamisole (substance) [SNOMED CT concept]
- Product containing levamisole (medicinal product) [SNOMED CT concept]
- levamisole [ATC Code]
- levamisole [Substance BNPC]
- levamisole [SNOMED Notion]
Validated automatic mappings to BTNT
- Levamisole hydrochloride (substance) [SNOMED CT concept]
- levamisole [ATC Code]

Position du mot-clé dans l'(les) arborescence(s) :

Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients